Back to News
Market Impact: 0.1
Boston Scientific Names Fitzgerald Executive Vice President & COO In New Operating Restructure
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
Boston Scientific appointed Joseph M. Fitzgerald executive vice president and chief operating officer, effective January 1, 2027. The article provides no further details on the appointment or its expected business impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
BSX0.10
More News
- Former world No. 1 Jon Rahm's lawyer tells court Spaniard is done with LIV Golf after three seasons
- Why Paramount-Warner merger has sparked fears about press freedom
- Profound Medical stock surges 20% on raised Q3 revenue outlook
- Amazon makes fresh job cuts, mainly in retail division
- Lululemon poaches Athleta CEO as new chief product officer
- $5 meals, $6 combos and fewer visits: McDonald’s barrage of deals isn’t winning customers back